DEERFIELD PARTNERS, LP
Insider CIK 1301041 · ATRS 10% owner · CBIO 10% owner · XNPT 10% owner · AUXL 10% owner · EHTH 10% owner · AERI 10% owner · VNDA 10% owner · PRTO 10% owner · ZFGN Director, 10% owner · ASPX 10% owner · SDGR 10% owner · AAVL 10% owner · AFIB Director, 10% owner · ANNX 10% owner · GRAY 10% owner · ACRS 10% owner · MNK 10% owner · LOXO 10% owner · REPH 10% owner · RGNX 10% owner · RVMD 10% owner · AVXS 10% owner · FIXX Director, 10% owner · ONCR Director, 10% owner · BDTX 10% owner · FREQ 10% owner · AHCO 10% owner · KNSA 10% owner · GBIO 10% owner · CABA 10% owner · HOWL 10% owner · NKTX 10% owner · DFPH Director, 10% owner · DFHT Director, 10% owner · TERN 10% owner · PEPG 10% owner · XLO 10% owner · OMIC 10% owner · NUVL Director, 10% owner · DALS Director, 10% owner · BCAX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 20,000 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 20,000 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 43,000 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 43,000 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 2,717,627 | $124.00 | $336.99M | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 2,717,627 | $124.00 | $336.99M | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 15,000 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 3,789 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 3,789 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 4,147 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 4,147 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 15,000 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer | 2026-07-15 | 2026-07-17 | 8,299,225 | $124.00 | $1.03B | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer | 2026-07-15 | 2026-07-17 | 8,299,225 | $124.00 | $1.03B | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer | 2026-07-15 | 2026-07-17 | 650,000 | $124.00 | $80.60M | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | U Tender | 2026-07-15 | 2026-07-17 | 5,146 | $124.00 | $638.1K | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer | 2026-07-15 | 2026-07-17 | 3,444 | $124.00 | $427.1K | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | U Tender | 2026-07-15 | 2026-07-17 | 5,146 | $124.00 | $638.1K | 0 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2026-02-27 | 2026-03-02 | 1,084,012 | $5.00 | $5.42M | 10,622,957 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2026-02-27 | 2026-03-02 | 831,978 | $5.00 | $4.16M | 8,153,107 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2026-02-27 | 2026-03-02 | 2,000,000 | $5.00 | $10.00M | 6,207,982 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2026-02-27 | 2026-03-02 | 1,084,010 | $5.00 | $5.42M | 10,622,928 | SEC↗ |
| NUVL Nuvalent, Inc. | S Sale | 2025-11-24 | 2025-11-24 | 371,287 | $95.45 | $35.44M | 8,299,225 | SEC↗ |
| NUVL Nuvalent, Inc. | S Sale | 2025-11-24 | 2025-11-24 | 371,287 | $95.45 | $35.44M | 8,299,225 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2025-07-31 | 2025-08-04 | 2,599,932 | $3.20 | $8.32M | 7,321,129 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2025-07-31 | 2025-08-04 | 3,387,539 | $3.20 | $10.84M | 9,538,945 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2025-07-31 | 2025-08-04 | 3,387,529 | $3.20 | $10.84M | 9,538,918 | SEC↗ |
| NUVL Nuvalent, Inc. | S Sale | 2024-10-22 | 2024-10-24 | 1,000,000 | $97.75 | $97.75M | 8,670,512 | SEC↗ |
| NUVL Nuvalent, Inc. | S Sale | 2024-10-22 | 2024-10-24 | 1,000,000 | $97.75 | $97.75M | 8,670,512 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion deriv | 2024-09-17 | 2024-09-17 | 7,973,325 | — | $0 | 0 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion deriv | 2024-09-17 | 2024-09-17 | 7,973,325 | — | $0 | 0 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | P Buy | 2024-09-17 | 2024-09-17 | 35,000 | $18.00 | $630.0K | 897,587 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | P Buy | 2024-09-17 | 2024-09-17 | 35,000 | $18.00 | $630.0K | 897,587 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion | 2024-09-17 | 2024-09-17 | 862,587 | — | $0 | 862,587 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | C Conversion | 2024-09-17 | 2024-09-17 | 862,587 | — | $0 | 862,587 | SEC↗ |
| AHCO AdaptHealth Corp. | S Sale | 2024-03-12 | 2024-03-12 | 114,906 | $10.70 | $1.23M | 11,528,863 | SEC↗ |
| AHCO AdaptHealth Corp. | S Sale | 2024-03-11 | 2024-03-12 | 94,567 | $10.92 | $1.03M | 11,731,809 | SEC↗ |
| AHCO AdaptHealth Corp. | S Sale | 2024-03-11 | 2024-03-12 | 88,040 | $11.13 | $979.9K | 11,643,769 | SEC↗ |
| AHCO AdaptHealth Corp. | S Sale | 2024-03-08 | 2024-03-12 | 4,495 | $11.03 | $49.6K | 11,826,376 | SEC↗ |
| AHCO AdaptHealth Corp. | S Sale | 2024-03-08 | 2024-03-12 | 47,992 | $10.92 | $524.1K | 11,830,871 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2024-02-16 | 2024-02-16 | 1,430,205 | $8.74 | $12.50M | 4,207,982 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2024-02-16 | 2024-02-16 | 1,430,206 | $8.74 | $12.50M | 6,151,389 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2024-02-16 | 2024-02-16 | 1,430,206 | $8.74 | $12.50M | 6,151,406 | SEC↗ |
| DALS DA32 Life Science Tech Acq | J Other | 2023-07-28 | 2023-08-01 | 1,600,000 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-30 | 2022-12-30 | 15,220 | $0.27 | $4.1K | 284,697 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-30 | 2022-12-30 | 61,826 | $0.27 | $16.7K | 1,156,309 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-30 | 2022-12-30 | 61,826 | $0.27 | $16.7K | 1,156,308 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-29 | 2022-12-30 | 63,107 | $0.26 | $16.4K | 1,218,135 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-29 | 2022-12-30 | 63,108 | $0.26 | $16.4K | 1,218,134 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-29 | 2022-12-30 | 15,538 | $0.26 | $4.0K | 299,917 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-28 | 2022-12-30 | 24,757 | $0.25 | $6.2K | 1,281,242 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-28 | 2022-12-30 | 6,096 | $0.25 | $1.5K | 315,455 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-28 | 2022-12-30 | 24,757 | $0.25 | $6.2K | 1,281,242 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-27 | 2022-12-27 | 7,136 | $0.27 | $1.9K | 321,551 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-27 | 2022-12-27 | 28,977 | $0.27 | $7.8K | 1,305,999 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-27 | 2022-12-27 | 28,977 | $0.27 | $7.8K | 1,305,999 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-22 | 2022-12-27 | 3,693 | $0.28 | $1.0K | 1,334,976 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-22 | 2022-12-27 | 3,692 | $0.28 | $1.0K | 1,334,976 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-22 | 2022-12-27 | 909 | $0.28 | $255 | 328,687 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-21 | 2022-12-21 | 6,144 | $0.30 | $1.8K | 1,338,668 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-21 | 2022-12-21 | 6,143 | $0.30 | $1.8K | 1,338,669 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-21 | 2022-12-21 | 1,513 | $0.30 | $454 | 329,596 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-20 | 2022-12-21 | 1,616 | $0.31 | $501 | 331,109 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-20 | 2022-12-21 | 6,562 | $0.31 | $2.0K | 1,344,812 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-20 | 2022-12-21 | 6,562 | $0.31 | $2.0K | 1,344,812 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-19 | 2022-12-21 | 44,394 | $0.29 | $12.9K | 1,351,374 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-19 | 2022-12-21 | 44,394 | $0.29 | $12.9K | 1,351,374 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-19 | 2022-12-21 | 10,930 | $0.29 | $3.2K | 332,725 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-15 | 2022-12-15 | 1,375 | $0.39 | $536 | 1,395,768 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-15 | 2022-12-15 | 339 | $0.39 | $132 | 343,655 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-15 | 2022-12-15 | 1,375 | $0.39 | $536 | 1,395,768 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-14 | 2022-12-15 | 943 | $0.38 | $358 | 343,994 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-14 | 2022-12-15 | 3,829 | $0.38 | $1.5K | 1,397,143 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-14 | 2022-12-15 | 3,828 | $0.38 | $1.5K | 1,397,143 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-13 | 2022-12-15 | 934 | $0.41 | $383 | 1,400,971 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-13 | 2022-12-15 | 933 | $0.41 | $383 | 1,400,972 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-13 | 2022-12-15 | 230 | $0.41 | $94 | 344,937 | SEC↗ |
| NUVL Nuvalent, Inc. | P Buy | 2022-11-03 | 2022-11-07 | 650,000 | $33.50 | $21.77M | 650,000 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award deriv | 2022-06-30 | 2022-07-05 | 1,889,509 | — | $0 | 1,889,509 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award deriv | 2022-06-30 | 2022-07-05 | 1,889,509 | — | $0 | 1,889,509 | SEC↗ |
| PEPG PepGen Inc. | C Conversion deriv | 2022-05-10 | 2022-05-10 | 273,313 | — | $0 | 0 | SEC↗ |
| PEPG PepGen Inc. | C Conversion deriv | 2022-05-10 | 2022-05-10 | 273,313 | — | $0 | 0 | SEC↗ |
| PEPG PepGen Inc. | P Buy | 2022-05-10 | 2022-05-10 | 208,333 | $12.00 | $2.50M | 476,813 | SEC↗ |
| PEPG PepGen Inc. | P Buy | 2022-05-10 | 2022-05-10 | 208,333 | $12.00 | $2.50M | 476,813 | SEC↗ |
| PEPG PepGen Inc. | C Conversion | 2022-05-10 | 2022-05-10 | 268,480 | — | $0 | 268,480 | SEC↗ |
| PEPG PepGen Inc. | C Conversion | 2022-05-10 | 2022-05-10 | 268,480 | — | $0 | 268,480 | SEC↗ |
| DFPH Oncology Institute, Inc. | C Conversion deriv | 2021-11-12 | 2021-11-16 | 85,113 | — | $0 | 0 | SEC↗ |
| DFPH Oncology Institute, Inc. | J Other deriv | 2021-11-12 | 2021-11-16 | 625,000 | — | $0 | 625,000 | SEC↗ |
| DFPH Oncology Institute, Inc. | P Buy deriv | 2021-11-12 | 2021-11-16 | 50,000 | $1000.00 | $50.00M | 58,945 | SEC↗ |
| DFPH Oncology Institute, Inc. | P Buy deriv | 2021-11-12 | 2021-11-16 | 50,000 | $1000.00 | $50.00M | 58,945 | SEC↗ |
| DFPH Oncology Institute, Inc. | J Other deriv | 2021-11-12 | 2021-11-16 | 707,960 | — | $0 | 40 | SEC↗ |
| DFPH Oncology Institute, Inc. | J Other deriv | 2021-11-12 | 2021-11-16 | 14,887 | — | $0 | 85,113 | SEC↗ |
| DFPH Oncology Institute, Inc. | C Conversion deriv | 2021-11-12 | 2021-11-16 | 40 | — | $0 | 0 | SEC↗ |
| DFPH Oncology Institute, Inc. | J Other deriv | 2021-11-12 | 2021-11-16 | 3,177,543 | — | $0 | 3,177,543 | SEC↗ |
| DFPH Oncology Institute, Inc. | J Other deriv | 2021-11-12 | 2021-11-16 | 625,000 | — | $0 | 625,000 | SEC↗ |
| DFPH Oncology Institute, Inc. | C Conversion | 2021-11-12 | 2021-11-16 | 85,113 | — | $0 | 85,113 | SEC↗ |
| DFPH Oncology Institute, Inc. | C Conversion | 2021-11-12 | 2021-11-16 | 40 | — | $0 | 40 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion deriv | 2021-10-26 | 2021-10-28 | 7,186,489 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion deriv | 2021-10-26 | 2021-10-28 | 7,186,489 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion | 2021-10-26 | 2021-10-28 | 756,472 | — | $0 | 756,472 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion | 2021-10-26 | 2021-10-28 | 756,472 | — | $0 | 756,472 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | P Buy | 2021-10-26 | 2021-10-28 | 387,500 | $16.00 | $6.20M | 1,143,972 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | P Buy | 2021-10-26 | 2021-10-28 | 387,500 | $16.00 | $6.20M | 1,143,972 | SEC↗ |
| DALS DA32 Life Science Tech Acq | D To issuer deriv | 2021-08-05 | 2021-08-09 | 701,250 | — | $0 | 4,465,000 | SEC↗ |
| DALS DA32 Life Science Tech Acq | A Award | 2021-07-30 | 2021-08-03 | 650,000 | $10.00 | $6.50M | 2,250,000 | SEC↗ |
| DALS DA32 Life Science Tech Acq | P Buy | 2021-07-30 | 2021-08-03 | 1,600,000 | $10.00 | $16.00M | 1,600,000 | SEC↗ |
| AFIB Acutus Medical, Inc. | P Buy | 2021-07-19 | 2021-07-21 | 390,836 | $14.00 | $5.47M | 1,974,638 | SEC↗ |
| AFIB Acutus Medical, Inc. | P Buy | 2021-07-19 | 2021-07-21 | 680,592 | $14.00 | $9.53M | 3,438,589 | SEC↗ |
| CMAX Deerfield Healthcare Techn | M Exercise deriv | 2021-06-08 | 2021-06-10 | 3,368,750 | — | $0 | 0 | SEC↗ |
| CMAX Deerfield Healthcare Techn | M Exercise deriv | 2021-06-08 | 2021-06-10 | 50,000 | — | $0 | 0 | SEC↗ |
| CMAX Deerfield Healthcare Techn | J Other deriv | 2021-06-08 | 2021-06-10 | 672,000 | — | $0 | 672,000 | SEC↗ |
| CMAX Deerfield Healthcare Techn | A Award deriv | 2021-06-08 | 2021-06-10 | 2,916,667 | — | $0 | 2,916,667 | SEC↗ |
| CMAX Deerfield Healthcare Techn | A Award | 2021-06-08 | 2021-06-10 | 9,600,000 | $10.00 | $96.00M | 12,960,000 | SEC↗ |
| CMAX Deerfield Healthcare Techn | A Award | 2021-06-08 | 2021-06-10 | 400,000 | $10.00 | $4.00M | 400,000 | SEC↗ |
| CMAX Deerfield Healthcare Techn | M Exercise | 2021-06-08 | 2021-06-10 | 3,368,750 | — | $0 | 3,768,750 | SEC↗ |
| CMAX Deerfield Healthcare Techn | M Exercise | 2021-06-08 | 2021-06-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OMIC Singular Genomics Systems, | C Conversion deriv | 2021-06-01 | 2021-06-03 | 0 | — | $0 | 0 | SEC↗ |
| OMIC Singular Genomics Systems, | C Conversion deriv | 2021-06-01 | 2021-06-03 | 0 | — | $0 | 0 | SEC↗ |
| OMIC Singular Genomics Systems, | C Conversion deriv | 2021-06-01 | 2021-06-03 | 6,457,723 | — | $0 | 0 | SEC↗ |
| OMIC Singular Genomics Systems, | P Buy | 2021-06-01 | 2021-06-03 | 450,000 | $22.00 | $9.90M | 7,484,871 | SEC↗ |
| OMIC Singular Genomics Systems, | C Conversion | 2021-06-01 | 2021-06-03 | 577,148 | $17.60 | $10.16M | 577,148 | SEC↗ |
| OMIC Singular Genomics Systems, | C Conversion | 2021-06-01 | 2021-06-03 | 577,148 | $17.60 | $10.16M | 7,034,871 | SEC↗ |
| OMIC Singular Genomics Systems, | C Conversion | 2021-06-01 | 2021-06-03 | 6,457,723 | — | $0 | 6,457,723 | SEC↗ |
| OMIC Singular Genomics Systems, | P Buy | 2021-06-01 | 2021-06-03 | 1,050,000 | $22.00 | $23.10M | 1,627,148 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | C Conversion deriv | 2021-05-04 | 2021-05-04 | 15,195,094 | — | $0 | 0 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | P Buy | 2021-05-04 | 2021-05-04 | 800,000 | $16.00 | $12.80M | 2,552,787 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | C Conversion | 2021-05-04 | 2021-05-04 | 1,752,787 | — | $0 | 1,752,787 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2021-02-17 | 2021-02-18 | 32,884 | $19.00 | $624.8K | 345,167 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2021-02-17 | 2021-02-18 | 133,558 | $19.00 | $2.54M | 1,401,905 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2021-02-17 | 2021-02-18 | 133,558 | $19.00 | $2.54M | 1,401,905 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 1,717,033 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2021-02-09 | 2021-02-09 | 665,000 | $17.00 | $11.30M | 2,382,033 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion | 2021-02-09 | 2021-02-09 | 1,717,033 | — | $0 | 1,717,033 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 2,449,761 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 7,499,999 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 7,499,999 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 2,449,761 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 2,449,761 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 202,670 | — | $0 | 823,150 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2020-10-06 | 2020-10-08 | 445,194 | $15.00 | $6.68M | 1,268,344 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2020-10-06 | 2020-10-08 | 445,194 | $15.00 | $6.68M | 1,268,344 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 202,670 | — | $0 | 202,670 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2020-10-06 | 2020-10-08 | 109,612 | $15.00 | $1.64M | 312,282 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 202,670 | — | $0 | 823,150 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 620,480 | — | $0 | 620,480 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 620,480 | — | $0 | 620,480 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion deriv | 2020-09-29 | 2020-10-01 | 2,624,901 | — | $0 | 0 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion deriv | 2020-09-29 | 2020-10-01 | 2,624,901 | — | $0 | 0 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion deriv | 2020-09-29 | 2020-10-01 | 12,809,912 | — | $0 | 0 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion deriv | 2020-09-29 | 2020-10-01 | 12,809,910 | — | $0 | 0 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion deriv | 2020-09-29 | 2020-10-01 | 2,624,901 | — | $0 | 0 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion | 2020-09-29 | 2020-10-01 | 291,467 | — | $0 | 291,467 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion | 2020-09-29 | 2020-10-01 | 291,467 | — | $0 | 1,713,873 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | P Buy | 2020-09-29 | 2020-10-01 | 1,562,500 | $16.00 | $25.00M | 1,853,967 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion | 2020-09-29 | 2020-10-01 | 1,422,406 | — | $0 | 1,422,406 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion | 2020-09-29 | 2020-10-01 | 1,422,406 | — | $0 | 1,422,406 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion | 2020-09-29 | 2020-10-01 | 291,467 | — | $0 | 1,713,873 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 449,992 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 1,002,464 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 189,366 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion deriv | 2020-08-10 | 2020-08-12 | 1,199,980 | — | $0 | 0 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion | 2020-08-10 | 2020-08-12 | 1,199,980 | — | $0 | 1,199,980 | SEC↗ |
| AFIB Acutus Medical, Inc. | P Buy | 2020-08-10 | 2020-08-12 | 944,444 | $18.00 | $17.00M | 1,583,802 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion | 2020-08-10 | 2020-08-12 | 1,002,464 | — | $0 | 2,202,444 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion | 2020-08-10 | 2020-08-12 | 189,366 | — | $0 | 639,358 | SEC↗ |
| AFIB Acutus Medical, Inc. | P Buy | 2020-08-10 | 2020-08-12 | 555,556 | $18.00 | $10.00M | 2,758,000 | SEC↗ |
| AFIB Acutus Medical, Inc. | C Conversion | 2020-08-10 | 2020-08-12 | 449,992 | — | $0 | 449,992 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award deriv | 2020-08-05 | 2020-08-12 | 12,454 | — | $0 | 12,454 | SEC↗ |
| AFIB Acutus Medical, Inc. | A Award | 2020-08-05 | 2020-08-12 | 2,222 | — | $0 | 2,222 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 4,043,032 | — | $0 | 0 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 4,043,031 | — | $0 | 0 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 458,914 | — | $0 | 458,914 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 458,914 | — | $0 | 458,914 | SEC↗ |
| ANNX Annexon, Inc. | P Buy | 2020-07-28 | 2020-07-28 | 350,000 | $17.00 | $5.95M | 808,914 | SEC↗ |
| ANNX Annexon, Inc. | P Buy | 2020-07-28 | 2020-07-28 | 350,000 | $17.00 | $5.95M | 808,914 | SEC↗ |
| DFHT Deerfield Healthcare Techn | J Other | 2020-07-21 | 2020-07-22 | 3,360,000 | $10.00 | $33.60M | 3,360,000 | SEC↗ |
| NKTX Nkarta, Inc. | C Conversion deriv | 2020-07-14 | 2020-07-14 | 2,626,767 | — | $0 | 0 | SEC↗ |
| NKTX Nkarta, Inc. | C Conversion deriv | 2020-07-14 | 2020-07-14 | 2,626,767 | — | $0 | 0 | SEC↗ |
| NKTX Nkarta, Inc. | P Buy | 2020-07-14 | 2020-07-14 | 500,000 | $18.00 | $9.00M | 1,209,936 | SEC↗ |
| NKTX Nkarta, Inc. | P Buy | 2020-07-14 | 2020-07-14 | 500,000 | $18.00 | $9.00M | 1,209,936 | SEC↗ |
| NKTX Nkarta, Inc. | C Conversion | 2020-07-14 | 2020-07-14 | 709,936 | — | $0 | 709,936 | SEC↗ |
| NKTX Nkarta, Inc. | C Conversion | 2020-07-14 | 2020-07-14 | 709,936 | — | $0 | 709,936 | SEC↗ |
| GBIO Generation Bio Co. | C Conversion deriv | 2020-06-16 | 2020-06-16 | 1,093,410 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | C Conversion deriv | 2020-06-16 | 2020-06-16 | 455,500 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | C Conversion | 2020-06-16 | 2020-06-16 | 703,332 | — | $0 | 703,332 | SEC↗ |
| GBIO Generation Bio Co. | C Conversion | 2020-06-16 | 2020-06-16 | 257,883 | — | $0 | 961,215 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2020-06-16 | 2020-06-16 | 225,000 | $19.00 | $4.28M | 1,186,215 | SEC↗ |
| DFPH DFP HEALTHCARE ACQUISITION | J Other | 2020-03-13 | 2020-03-17 | 2,500,000 | $10.00 | $25.00M | 2,500,000 | SEC↗ |
| DFPH DFP HEALTHCARE ACQUISITION | J Other | 2020-03-13 | 2020-03-17 | 2,500,000 | $10.00 | $25.00M | 2,500,000 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion deriv | 2020-02-18 | 2020-02-18 | 997,589 | — | $0 | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion deriv | 2020-02-18 | 2020-02-18 | 498,795 | — | $0 | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion | 2020-02-18 | 2020-02-18 | 997,589 | — | $0 | 997,589 | SEC↗ |
| RVMD Revolution Medicines, Inc. | P Buy | 2020-02-18 | 2020-02-18 | 300,000 | $17.00 | $5.10M | 798,795 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion | 2020-02-18 | 2020-02-18 | 498,795 | — | $0 | 498,795 | SEC↗ |
| RVMD Revolution Medicines, Inc. | P Buy | 2020-02-18 | 2020-02-18 | 300,000 | $17.00 | $5.10M | 1,297,589 | SEC↗ |
| SDGR Schrodinger, Inc. | C Conversion deriv | 2020-02-10 | 2020-02-10 | 10,063,061 | — | $0 | 0 | SEC↗ |
| SDGR Schrodinger, Inc. | P Buy | 2020-02-10 | 2020-02-10 | 250,000 | $17.00 | $4.25M | 250,000 | SEC↗ |
| SDGR Schrodinger, Inc. | C Conversion | 2020-02-10 | 2020-02-10 | 1,346,167 | — | $0 | 1,346,167 | SEC↗ |
| BDTX Black Diamond Therapeutics | C Conversion deriv | 2020-02-03 | 2020-02-03 | 1,142,361 | — | $0 | 0 | SEC↗ |
| BDTX Black Diamond Therapeutics | P Buy | 2020-02-03 | 2020-02-03 | 400,000 | $19.00 | $7.60M | 778,790 | SEC↗ |
| BDTX Black Diamond Therapeutics | C Conversion | 2020-02-03 | 2020-02-03 | 378,790 | — | $0 | 378,790 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-01-30 | 2020-01-31 | 509,970 | $15.45 | $7.88M | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-01-29 | 2020-01-31 | 8,857 | $15.45 | $136.8K | 509,970 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-01-28 | 2020-01-28 | 65,891 | $15.51 | $1.02M | 518,827 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-01-27 | 2020-01-28 | 193,359 | $15.77 | $3.05M | 584,718 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-01-24 | 2020-01-28 | 380,256 | $15.69 | $5.97M | 778,077 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-24 | 2019-12-27 | 198,767 | $21.95 | $4.36M | 2,321,199 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-24 | 2019-12-27 | 151,233 | $21.95 | $3.32M | 1,766,106 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-23 | 2019-12-23 | 56,595 | $21.83 | $1.24M | 1,917,339 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-23 | 2019-12-23 | 74,384 | $21.83 | $1.62M | 2,519,966 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-20 | 2019-12-23 | 9,130 | $21.50 | $196.3K | 1,973,934 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-20 | 2019-12-23 | 11,999 | $21.50 | $258.0K | 2,594,350 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-19 | 2019-12-23 | 5,454 | $21.68 | $118.2K | 1,983,064 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-19 | 2019-12-23 | 7,168 | $21.68 | $155.4K | 2,606,349 | SEC↗ |
| CABA Cabaletta Bio, Inc. | C Conversion deriv | 2019-10-29 | 2019-10-30 | 696,379 | — | $0 | 0 | SEC↗ |
| CABA Cabaletta Bio, Inc. | C Conversion deriv | 2019-10-29 | 2019-10-30 | 696,379 | — | $0 | 0 | SEC↗ |
| CABA Cabaletta Bio, Inc. | P Buy | 2019-10-29 | 2019-10-30 | 700,000 | $11.00 | $7.70M | 700,000 | SEC↗ |
| CABA Cabaletta Bio, Inc. | C Conversion | 2019-10-29 | 2019-10-30 | 464,253 | — | $0 | 464,253 | SEC↗ |
| CABA Cabaletta Bio, Inc. | C Conversion | 2019-10-29 | 2019-10-30 | 464,253 | — | $0 | 464,253 | SEC↗ |
| FREQ Frequency Therapeutics, In | C Conversion deriv | 2019-10-07 | 2019-10-07 | 3,184,948 | — | $0 | 0 | SEC↗ |
| FREQ Frequency Therapeutics, In | C Conversion deriv | 2019-10-07 | 2019-10-07 | 3,184,948 | — | $0 | 0 | SEC↗ |
| FREQ Frequency Therapeutics, In | P Buy | 2019-10-07 | 2019-10-07 | 285,714 | $14.00 | $4.00M | 285,714 | SEC↗ |
| FREQ Frequency Therapeutics, In | C Conversion | 2019-10-07 | 2019-10-07 | 472,860 | — | $0 | 472,860 | SEC↗ |
| FREQ Frequency Therapeutics, In | C Conversion | 2019-10-07 | 2019-10-07 | 472,860 | — | $0 | 472,860 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-06-27 | 2019-07-01 | 108,674 | $2.69 | $292.3K | 964,101 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-06-27 | 2019-07-01 | 590,801 | $2.69 | $1.59M | 3,159,165 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-06-26 | 2019-06-26 | 352 | $4.50 | $1.6K | 1,072,775 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-06-26 | 2019-06-26 | 1,352 | $4.50 | $6.1K | 3,749,966 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-06-25 | 2019-06-25 | 10,634 | $4.51 | $48.0K | 1,073,127 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-06-25 | 2019-06-25 | 40,850 | $4.51 | $184.2K | 3,751,318 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-06-24 | 2019-06-25 | 13,063 | $4.52 | $59.0K | 1,083,761 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-06-24 | 2019-06-25 | 50,177 | $4.52 | $226.8K | 3,792,168 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-06-21 | 2019-06-25 | 70,135 | $4.62 | $324.0K | 1,096,824 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-06-21 | 2019-06-25 | 269,402 | $4.62 | $1.24M | 3,842,345 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-05-10 | 2019-05-13 | 108,696 | $6.05 | $657.6K | 4,111,747 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-05-10 | 2019-05-13 | 71,869 | $6.05 | $434.8K | 1,166,959 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-05-09 | 2019-05-13 | 172,800 | $6.16 | $1.06M | 1,238,828 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-05-09 | 2019-05-13 | 261,345 | $6.16 | $1.61M | 4,220,443 | SEC↗ |
| FIXX Homology Medicines, Inc. | P Buy | 2019-04-12 | 2019-04-15 | 533,333 | $22.50 | $12.00M | 1,158,333 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other deriv | 2019-01-15 | 2019-01-18 | 1 | — | $0 | 1 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other deriv | 2019-01-14 | 2019-01-18 | 1 | — | $0 | 1 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other deriv | 2019-01-11 | 2019-01-18 | 1 | — | $0 | 1 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other deriv | 2018-12-28 | 2019-01-02 | 1 | — | $0 | 1 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other deriv | 2018-12-27 | 2018-12-27 | 1 | — | $0 | 1 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other deriv | 2018-12-26 | 2018-12-27 | 1 | — | $0 | 1 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other deriv | 2018-12-24 | 2018-12-27 | 1 | — | $0 | 1 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other deriv | 2018-12-21 | 2018-12-21 | 1 | — | $0 | 1 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other deriv | 2018-12-20 | 2018-12-21 | 1 | — | $0 | 1 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other deriv | 2018-12-19 | 2018-12-21 | 1 | — | $0 | 1 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion deriv | 2018-05-29 | 2018-05-31 | 383,538 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | P Buy | 2018-05-29 | 2018-05-31 | 25,000 | $20.91 | $522.8K | 608,333 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | P Buy | 2018-05-29 | 2018-05-31 | 250,000 | $19.81 | $4.95M | 583,333 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | P Buy | 2018-05-29 | 2018-05-31 | 235,019 | $19.24 | $4.52M | 843,352 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion | 2018-05-29 | 2018-05-31 | 383,538 | — | $0 | 383,538 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | P Buy | 2018-05-29 | 2018-05-31 | 333,333 | $18.00 | $6.00M | 333,333 | SEC↗ |
| MNK Mallinckrodt plc | S Sale | 2018-05-09 | 2018-05-10 | 202,006 | $13.74 | $2.78M | 8,308,455 | SEC↗ |
| MNK Mallinckrodt plc | S Sale | 2018-05-09 | 2018-05-10 | 110,922 | $12.75 | $1.41M | 8,510,461 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 6,944,444 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 6,944,445 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 3,521,126 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 3,521,126 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion | 2018-04-02 | 2018-04-04 | 669,034 | — | $0 | 669,034 | SEC↗ |
| FIXX Homology Medicines, Inc. | P Buy | 2018-04-02 | 2018-04-04 | 625,000 | $16.00 | $10.00M | 625,000 | SEC↗ |
| FIXX Homology Medicines, Inc. | P Buy | 2018-04-02 | 2018-04-04 | 625,000 | $16.00 | $10.00M | 2,613,517 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion | 2018-04-02 | 2018-04-04 | 669,034 | — | $0 | 669,034 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion | 2018-04-02 | 2018-04-04 | 1,319,483 | — | $0 | 1,988,517 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion | 2018-04-02 | 2018-04-04 | 1,319,484 | — | $0 | 1,988,518 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-08 | 2018-03-21 | 5,890 | $29.03 | $171.0K | 807,257 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-08 | 2018-03-21 | 866 | $30.00 | $26.0K | 813,147 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-08 | 2018-03-21 | 2,233 | $29.03 | $64.8K | 305,965 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-08 | 2018-03-21 | 328 | $30.00 | $9.8K | 308,198 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-07 | 2018-03-21 | 2,748 | $30.00 | $82.4K | 308,526 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-07 | 2018-03-21 | 7,252 | $30.00 | $217.6K | 814,013 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-06 | 2018-03-21 | 10,802 | $31.18 | $336.8K | 311,274 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-06 | 2018-03-21 | 28,498 | $31.18 | $888.6K | 821,265 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-06 | 2018-03-21 | 3,617 | $29.94 | $108.3K | 322,076 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-06 | 2018-03-21 | 9,544 | $29.94 | $285.7K | 849,763 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | S Sale | 2017-11-30 | 2017-12-04 | 110,557 | $1.75 | $193.5K | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy | 2017-11-30 | 2017-12-04 | 110,557 | $1.75 | $193.5K | 197,424 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-06-14 | 2017-06-14 | 68,000 | $6.25 | $425.0K | 1,176,685 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-06-13 | 2017-06-14 | 32,447 | $6.59 | $213.8K | 1,244,685 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-06-12 | 2017-06-14 | 10,000 | $6.74 | $67.4K | 1,277,132 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-06-08 | 2017-06-09 | 17,245 | $6.99 | $120.5K | 1,287,132 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-06-07 | 2017-06-09 | 45,623 | $7.09 | $323.5K | 1,304,377 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-27 | 2017-04-27 | 183,805 | $11.71 | $2.15M | 244,562 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-27 | 2017-04-27 | 71,837 | $11.71 | $841.2K | 877,606 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-27 | 2017-04-27 | 58,067 | $11.71 | $680.0K | 709,386 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-26 | 2017-04-27 | 66,351 | $11.52 | $764.4K | 428,367 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-26 | 2017-04-27 | 20,962 | $11.52 | $241.5K | 767,453 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-26 | 2017-04-27 | 25,932 | $11.52 | $298.7K | 949,443 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-13 | 2017-04-17 | 34,349 | $11.00 | $377.8K | 975,375 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-13 | 2017-04-17 | 87,886 | $11.00 | $966.7K | 494,718 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-13 | 2017-04-17 | 27,765 | $11.00 | $305.4K | 788,415 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-11 | 2017-04-11 | 6,189 | $11.01 | $68.1K | 816,180 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-11 | 2017-04-11 | 19,593 | $11.01 | $215.7K | 582,604 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-11 | 2017-04-11 | 7,658 | $11.01 | $84.3K | 1,009,724 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-10 | 2017-04-11 | 18,264 | $11.04 | $201.6K | 1,017,382 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-10 | 2017-04-11 | 14,763 | $11.04 | $163.0K | 822,369 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-10 | 2017-04-11 | 46,730 | $11.04 | $515.9K | 602,197 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-07 | 2017-04-11 | 27,228 | $11.72 | $319.1K | 1,035,646 | SEC↗ |